Evidence map›Paper›PMID 35164046›Full record

ArticleMolecules (Basel, Switzerland)2022

Miodesin

Carlos Rocha Oliveira, Hudson Polonini, Maria Cristina Marcucci, Rodolfo P Vieira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Single-Cell Transcriptomics Reveals CCL3Journal of inflammation research · 2025
    Article
  2. Application of the Extracts ofJournal of clinical medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Carlos Rocha OliveiraSchool of Medicine, Anhembi Morumbi University, Avenida Deputado Benedito Matarazzo 6070, Sao Jose dos Campos 12231-280, SP, Brazil.
Hudson PoloniniFagron BV, Fascinatio Boulevard 350, 3065 WB Rotterdam, The Netherlands.ORCID 0000-0002-2119-3660
Maria Cristina MarcucciDepartment of Biosciences and Oral Diagnosis, Institute of Science and Technology, Universidade Estadual Paulista-UNESP, Sao Jose dos Campos 12231-280, SP, Brazil.ORCID 0000-0002-8065-5618
Rodolfo P VieiraPost-graduation Program in Sciences of Human Movement and Rehabilitation, Federal University of Sao Paulo (UNIFESP), Avenida Ana Costa 95, Santos 11060-001, SP, Brazil.ORCID 0000-0001-6379-1143
Anhembi Morumbi University · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Evangelica de Goiás · BR

Funding

Fagron do Brasil Pharmaceutical LTDA. N/A
6 · The paper itself

Abstract

Endometriosis presents high prevalence and its physiopathology involves hyperactivation of endometrial and vaginal cells, especially by bacteria. The disease has no cure and therapies aiming to inhibit its development are highly desirable. Therefore, this study investigated whether Miodesin

Indexed as

Biological ProductsCandida albicansChemokinesCytokinesEndometriumFemaleHumansLipopolysaccharidesPhospholipases A2RNA, MessengerVaginaBiological ProductsChemokinesCytokinesLipopolysaccharidesPhospholipases A2RNA, Messengeranti-inflammatorychemokinesendometriosisleiomyomaMiodesinTM

Identifiers

PMID35164046
PMCPMC8837934
OpenAlexW4210748205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.